Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
KKR deepens Japan footprint with takeover of insurance distributor Hoken Minaoshi Hompo
KKR deepens Japan footprint with takeover of insurance distributor Hoken Minaoshi Hompo KKR has acquired Hoken Minaoshi Hompo Group, a leading Japanese insurance distributor, from Advantage Partners, marking the latest addition to its Asia private equity portfolio....
BlueFive Capital eyes $1bn close for new Asia fund by year-end
BlueFive Capital eyes $1bn close for new Asia fund by year-end Abu Dhabi-based BlueFive Capital is preparing to close a $1bn Asia-focused private equity fund by the fourth quarter of 2025, targeting high-growth opportunities in infrastructure, aviation, and mining....
Hellman & Friedman-backed Verisure prepares €3.1bn debut on Swedish exchange
Hellman & Friedman-backed Verisure prepares €3.1bn debut on Swedish exchange Private equity-backed security group Verisure has announced plans to raise €3.1bn in an initial public offering in Stockholm, in what could be one of the largest European IPOs in recent...